Mission

Digitise R&D past for a better future

Since 2013, Integle Informatics has been focusing on developing independently on ELN technologies, which has to be built to meet international standards and fully meet regulation requirements of FDA，NMPA and EMEA.

Leading global companies such as Hengrui (top 20 big pharma), Staidson Biopharma (San Francisco) and other 20+ listed companies have established cooperation with Integle Informatics.